Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

Aljanae Reynolds Wheelhouse Life Science Advisors areynolds@wheelhouselsa.com Kris Fortner Nurix Therapeutics Kfortner@nurixtx.com Contacts: Investors Kris Fortner Nurix Therapeutics, Inc. kfortner@nurixtx.com Elizabeth Wolffe, Ph.D. Wheelhouse Life Science Advisors lwolffe@wheelhouselsa.com Media SAN FRANCISCO, May 28, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein d ...